GlassScriptPhysician profile
Chrisanne Gennille Roach
NPI 1518461540
$314.44
in general payments reported to CMS, 2019-2025
14 companies · $73.08 in 2025
The $73.08 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $29.95 · 2023: $86.63 · 2024: $125 · 2025: $73.08.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $284.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $284.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $40.63 | 2025 | Veozah |
| Shield Therapeutics INC | $37.56 | 2023-2024 | Accrufer |
| Abbvie INC. | $37.25 | 2022-2023 | Liletta |
| Davol INC. | $34.16 | 2023-2024 | |
| Hologic Sales and Service, LLC | $20.89 | 2024 | Fluent Fluid Management System, Myosure Tissue Removal Device, Acessa Provu System |
| Medtronic, INC. | $18.43 | 2024 | Truclear |
| Coopersurgical, INC. | $18.37 | 2024 | Paragard T 380a |
| Exeltis, USA INC. | $18.14 | 2023 | Slynd |
| Ethicon US, LLC | $17.35 | 2025 | Harmonic |
| Mayne Pharma Commercial LLC | $15.47 | 2023 | |
| Biogen, INC. | $15.10 | 2025 | Zurzuvae |
| Amgen INC. | $14.52 | 2024 | Evenity, Prolia |
| Aspira Women'S Health INC | $14.15 | 2024 | Ova1 |
| Bayer Healthcare Pharmaceuticals INC. | $12.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chrisanne Roach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.